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Background: The prevalence of metabolic syndrome (MetS) has increased in developing countries in recent
decades. This syndrome, a clustering of metabolic abnormalities, has been correlated to various socioeconomic and
behavioral variables. We investigated the prevalence and prevalence ratios (PR) of MetS and related factors in an
adult population of the Federal District (FD) of Brazil, which is located in the central region of the country.
Methods: A cross-sectional, population-based study conducted in 2007, with 2130 adults (aged 18 years or older) in
the FD of Brazil. Metabolic syndrome was defined according to the recently harmonized criteria. The prevalence of
MetS and PR were estimated for each sex according to the diagnostic components and the overall contribution of
the selected correlates.
Results: The overall prevalence of MetS was 32.0% (95%CI: 28.9–35.2), with no gender difference. The single
component with the greatest contribution to the diagnosis of MetS was hypertension in men (PR 5.10, 95%CI:
3.17–8.22) and high waist circumference in women (PR 5.02, 95%CI: 3.77–6.69). The prevalence of MetS increased
significantly and progressively with age and excess weight. In women, higher education was protective against
MetS (PR 0.66, 95%CI: 0.49–0.89) compared to 8 or less years of education. There was no association between the
prevalence of MetS and behavioral variables studied.
Conclusions: This study provides comprehensive and alarming data about the prevalence of MetS among the adult
population of Brazil’s FD. The results suggest that reducing education inequalities may be an important public
policy goal to improve health outcomes, especially among women.
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The burden of chronic non-communicable diseases (NCD)
in developing countries continues to rise, with high mor-
bidity and mortality due to cardiovascular diseases (CVD)
[1,2]. Metabolic syndrome (MetS) is a complex disorder
characterized by the association of cardiovascular risk fac-
tors and insulin resistance. The factors that define MetS
include central obesity, dyslipidemia, hypertension and
altered glucose metabolism [3]. The risk associated with
CVD and type 2 diabetes increases as a cluster [4-6] or in
accordance with individual components of MetS [7,8].
While debate continues over the definition of MetS, its* Correspondence: marina@unb.br
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reproduction in any medium, provided the orclinical significance and value as an independent risk mar-
ker for cardiovascular disease (CVD) remains high [9,10].
Likewise, the public health relevance of MetS for
countries in which economic resources are limited is un-
questionable. Government policies to prevent CVD may be
optimized when aimed to prevent and treat MetS as a
whole rather than its individual risk factors [11].
Globally, the overall prevalence of MetS may vary
according to the population, gender, age, geographic lo-
cation, other correlated variables and the diagnostic
criteria used [12,13]. In addition, its prevalence has
increased in developing countries in recent decades [11].
The Cardiovascular Risk Factor Multiple Evaluation in
Latin America (CARMELA) study included an assess-
ment of MetS in seven urban Hispanic Latin American
adult populations. The prevalence of MetS, definedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Dutra et al. Diabetology & Metabolic Syndrome 2012, 4:20 Page 2 of 9
http://www.dmsjournal.com/content/4/1/20according to the National Cholesterol Education Program
Adult Treatment Panel III – NCEP/ATP III [14], was
highest among CARMELA cities in Mexico City (27%) and
lowest in Quito (14%) [15].
Underprivileged urban populations from developing
countries have been shown to have an increased
prevalence of overweight [16] and other risk factors for
CVD [11]. Brazil is a non-Hispanic middle income
country, and CVD is the leading cause of mortality there.
Low income segments of the population are the most
affected, especially with respect to premature deaths
attributable to CVD [17]. In the few population studies
conducted in Brazil, MetS prevalence ranged from 19%
[18] to 25% [19] in urban populations. Among
socioeconomic factors, educational inequality has con-
sistently been associated with an increased risk of MetS
in different populations [11,20,21], but this association
has not been demonstrated for the South American
population.
Recently, to simplify the diagnostic process and allow for
comparison between countries, a unifying world-wide con-
sensus definition for MetS was proposed [3]. According to
the harmonized criteria, population and country-specific
definitions for waist circumference thresholds should be
used.
The aim of this study was to use the new consensus
definitions to estimate the prevalence and prevalence
ratios (PR) of MetS in the adult population of Brazil’s
Federal District (FD), which includes the capital city
Brasilia. Furthermore, the study sought to investigate the
associated correlates for MetS prevalence in a sample
with a wider age range.
Methods
Brazil’s FD is located in the center of the country, with a
population of 2,434,033 inhabitants, 68.9% of whom are
18 years or older [22]. The population has a diverse
background, including people who were born locally and
those who came from other parts of the country during
the 50 years of the FD’s existence. This population-based
household cross-sectional study representative of the
population aged 18 years or older residing in the FD was
conducted in 2007 to investigate the prevalence and risk
factors associated with NCD. The study used a complex
sampling plan with a multistage probability cluster design
and with random sampling of census sectors, households
and one adult per household in urban and rural areas of
the FD [22]. The sample loss was considered to be 20%.
Pregnant women and adults unable to understand or
respond independently were excluded from the survey. Of
the 2,726 adults that comprised the study sample, 2,130
individuals constituted the final sample that had
anthropometric measurements taken and biochemical
tests performed.The study protocol was approved by the University of
Brasilia’s Faculty of Health Sciences Research Ethics
Committee, and informed consent was obtained from each
participant. Household questionnaires were administered
in face-to-face interviews. Interviewers were trained health
sciences students or professionals. Reproducibility tests
were conducted to guarantee reliable instrument and
interviewer performance.
Anthropometric measurements were obtained twice
with the participant in light clothing and barefoot. Body
weight was measured using a digital scale, and height was
determined by a portable stadiometer for body mass index
(BMI) calculation (kg/m2). Waist circumference (WC) was
measured to the nearest millimeter and taken midway be-
tween the lower limit of the rib cage and the iliac crest
using a non-stretchable nylon tape. Arterial blood pressure
readings were measured twice (15 min interval) in a seated
position with an automatic apparatus (Omron, model
HEM-705CP, USA), and the mean of the two values was
calculated.
For biochemical tests, 12 h overnight fasting blood sam-
ples were assayed by standard methods for glucose, total
cholesterol (TC), high-density lipoprotein cholesterol
(HDLc) and triglycerides (TG) using an automatic
biochemical analyzer Konelab 60i (Thermo Electron Co.,
USA). Low-density lipoprotein cholesterol (LDLc) was
calculated by the Friedewald equation, excluding samples
with triglyceride values> 400 mg/dL [23].
This study used the harmonized MetS criteria [3].
Metabolic syndrome (the dependent variable) was consid-
ered present when at least three of the following
characteristics were observed: TG≥ 150 mg/dL; HDLc
< 40 mg/dL in men or< 50 mg/dL in women; systolic
arterial blood pressure≥ 130 mmHg and/or diastolic arter-
ial blood pressure≥ 85 mmHg or anti-hypertensive treat-
ment; and glucose≥ 100 mg/dL or anti-diabetic treatment.
For abdominal obesity, the consensus calls for the
“population- and country- specific definition” of cut points
for elevated WC. No WC cut point of risk for MetS has
been established for the Brazilian population as a whole.
As Brazilians are predominantly of European ancestry
[24], we adopted WC threshold values of≥ 102 cm for
men and≥ 88 cm for women, one of the criteria recom-
mended by the harmonized consensus based on American
Heart Association/National Heart, Lung and, Blood Insti-
tute values for people of European origin [3].
The independent variables included socio-demographic,
behavioral, nutritional and health status. Sociodemographic
variables included age, sex, education, per capita income
(legal minimal wage (MW) at the time of the field work
US$150.00), time of residence in FD, marital status and self-
reported skin color. Behavioral variables were fruit and
vegetable intake, use of table salt, alcohol consumption and
smoking status. Physical activity level was assessed by the
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[25] and categorized into sufficiently active, insufficiently ac-
tive and inactive [26]. Aside from MetS defining factors, the
additional nutritional and health variables were BMI, TC
and LDLc.
Statistical analysis
To estimate the prevalence of MetS and associated fac-
tors, weighting factors were used so that a probability of
being sampled was assigned to each participant. This
procedure enabled the results to represent the adult
population of FD according to sex, age and education
level based on the official census data available at the
time of analysis [21].
The database was built by double typing. Sample weights
and the effect of complex sample design on the standard
errors were treated using the survey command of STATA
software version 9.2 (Stata Corp., College Station, Texas,
USA). Initially, the prevalence of MetS and the number of
MetS-defining components were calculated as well as the
socio-demographic variable distributions with 95% confi-
dence intervals (CI). Next, two multivariate models were
tested. In the first model, the prevalence ratios (PR) between
each diagnostic component and the MetS diagnosis with
95% CI were calculated to analyze the strength of the asso-
ciation between each MetS-defining component and
diagnosis. The second model analyzed the overall contribu-
tion of all the independent variables to MetS diagnosis
excluding the MetS-defining variables. In this model, after
the initial crude analysis, the variables with a significant as-
sociation with MetS were further adjusted. All the multi-
variate analyses were carried out using a Poisson regression
with robust variance (log-linear) for each sex. We used the
Poisson regression because it provides a better estimate of
the prevalence ratios, which in turn represent a more mean-
ingful effects measure for cross-sectional studies [27]. The
significance level was set at P-value< 0.05.
Results
The overall prevalence of MetS was 32.0%, with no dif-
ference observed between men (30.9%, 95%CI: 26.1–
35.6) and women (33.0%, 95%CI: 29.5–36.6). According
to the number of diagnostic components of MetS, only
13.6% had zero components, and 5.2% had all five
components (Table 1). The majority of subjects in the
study were female, younger than 45 years old, with a per
capita income below one minimum wage, married or
living with a partner, and 50% had up to 8 years of
schooling. The most frequently cited self-reported skin
color category was “mixed” (44.8%).
Table 2 summarizes the contribution of individual
diagnostic components to the observed PR for MetS. The
single crude component that contributed most to the
diagnosis of MetS was hypertension or elevated bloodpressure in men (PR 11.01, 95%CI: 6.41–18.93) and high
WC in women (PR 11.26, CI95%: 8.55–14.83). Adjustment
for all diagnostic components did not change these results,
and a high WC led to a greater than five-fold increase in
the prevalence of MetS among women (PR 5.02, CI95%:
3.77–6.69). The other two most important components
that increased MetS prevalence were hypertriglyceridemia
and low HDLc in men and low HDLc and elevated blood
pressure in women.
Tables 3 and 4 present PR according to sociodemo-
graphic, behavioral and selected health variables. In the
crude PR analysis, the following variables did not show
significance and were excluded: education, per capita in-
come, skin color, fruit and vegetable intake, extra table
salt, alcohol consumption, smoking and LDLc levels (for
males); and per capita income, skin color, fruit and vege-
table intake and current physical activity level (for
females; data not shown). Subsequently, in the multi-
variate analysis, the first adjustment was performed for
age. Among men (Table 3), variables that showed signifi-
cance at this level were age, BMI and TC. For women
(Table 4), age, education, marital status, alcohol con-
sumption, BMI and TC were significantly associated
with MetS.
After the final adjustment, the prevalence of MetS
increased significantly and progressively with age
(P< 0.001) and BMI≥ 25 kg/m2 (P <0.001) in both men
and women. For women (Table 4), there was a 20% in-
crease in the frequency of MetS in those with total choles-
terol levels greater than or equal to 200 mg/dL (P <0.05).
Only in women, higher education (12 or more years of
study) was protective against MetS (PR 0.66, 95% CI:
0.49–0.89). Younger women tended to have more than
12 years of education when compared to older women
(results not shown). No association was observed between
behavioral variables and the prevalence of MetS.
Discussion
To our knowledge, this is the first published population-
based study that determined the prevalence of MetS in
Central Brazil. The results indicate that the population of
the FD is at significant risk of morbidity and mortality
from CVD and type 2 diabetes due to the high prevalence
of MetS (32.0%). This disturbing result is not surprising
because trends of excess weight among Brazilians [28] and
the country’s surveillance system have pointed to the in-
creasing prevalence of excess weight and other factors
associated with cardiovascular risk in our adult population
[29]. Our results reinforce an alarming public health trend
[16,17].
The overall prevalence of MetS found in our study is
similar to that in the US population (34.0%) reported by
the 2003–2006 National Health and Nutrition Examin-
ation Survey (NHANES) [30]. Compared to other middle
Table 1 Prevalence and distribution of sociodemographic variables (%), metabolic syndrome (MetS) and number of its
components, among adults aged 18 years or older a (Federal District, Brazil, 2007)
Total (n=2130) Male (n = 586) Female (n = 1544)
Variable % 95%CI % 95%CI % 95%CI
MetS
No 68.0 (64.8 – 71.1) 69.1 (64.4 – 73.9) 67.0 (63.4 – 70.5)
Yes 32.0 (28.9 – 35.2) 30.9 (26.1 – 35.6) 33.0 (29.5 – 36.6)
MetS components number
0 13.6 (11.2 – 159) 14.8 (10.3 – 19.2) 12.5 (10.0 – 15.0)
1 31.8 (28.6 – 35.1) 31.2 (25.5 – 36.9) 32.4 (28.0 – 36.8)
2 22.6 (19.9 – 25.2) 23.2 (19.1 – 27.2) 22.0 (18.9 – 25.2)
3 15.7 (13.6 – 17.8) 15.2 (12.0 – 18.4) 16.1 (13.8 – 18.5)
4 11.1 (9.3 – 12.8) 10.5 (8.0 – 13.1) 11.6 (9.4 – 13.7)
5 5.2 (4.0 – 6.5) 5.1 (3.0 – 7.2) 5.3 (4.1 – 6.6)
Age (years)
18–24 24.8 (20.9 – 28.8) 25.3 (18.2 – 32.3) 24.5 (21.2 – 27.7)
25–34 28.6 (24.5 – 32.7) 28.9 (20.8 – 37.1) 28.3 (24.4 – 32.2)
35–44 21.1 (18.4 – 23.8) 20.8 (16.5 – 25.2) 21.3 (18.8 – 23.7)
45–54 13.4 (11.8 – 15.1) 13.3 (10.4 – 16.2) 13.5 (11.5 – 15.5)
55–64 7.1 (5.9 – 8.2) 7.2 (5.4 – 9.0) 7.0 (5.8 – 8.2)
≥65 5.0 (3.5 – 6.5) 4.5 (2.8 – 6.2) 5.5 (4.0 – 6.9)
Education (years)
0–8 50.1 (42.8 – 57.5) 51.9 (43.3 – 60.5) 48.6 (41.3 – 55.8)
9–11 31.3 (27.5 – 35.2) 29.3 (24.6 – 34.1) 33.1 (28.9 – 37.3)
≥ 12 18.5 (10.3 – 26.8) 18.8 (10.0 – 27.6) 18.3 (10.0 – 26.6)
Per capita income (minimal wages)
< 0.5 31.6 (24.3 – 38.9) 23.9 (15.5 – 32.2) 38.4 (29.9 – 47.0)
0.5–1.0 25.1 (20.3 – 29.9) 25.1 (17.8 – 32.4) 25.2 (20.6 – 29.8)
> 1.0 43.3 (33.9 – 52.6) 51.1 (40.6 – 61.6) 36.3 (26.3 – 46.4)
Marital status
Single 35.0 (30.8 – 39.2) 40.0 (32.7 – 47.3) 30.6 (26.5 – 34.6)
Married/living with partner 56.4 (52.4 – 60.4) 54.6 (47.1 – 62.1) 58.0 (53.3 – 62.6)
Widowed/separated 8.6 (6.9 – 10.3) 5.4 (2.7 – 8.0) 11.4 (9.3 – 13.6)
Skin color
Black 14.1 (11.1 – 17.1) 15.6 (10.7 – 20.5) 12.1 (7.9 – 16.4)
Mixed (“pardo”) 44.8 (38.6 – 51.0) 47.2 (37.8 – 56.6) 42.7 (37.1 – 48.3)
White 30.3 (23.5 – 37.2) 28.0 (18.9 – 37.2) 32.3 (26.3 – 38.3)
Others 10.8 (6.3 – 15.2) 9.2 (3.7 – 14.7) 12.1 (7.9 – 16.4)
a Weighted to represent distributions of population aged 18 years or older, according to gender, age and education based on Brazilian national census for the year
2000.
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31.2%, [31] greater than the 26.9% described for Peru [32],
and lower than the 41.4% reported in India [33]. Apart
from methodological differences between studies, variabil-
ity in the prevalence of MetS between populations could
be explained by demographic, epidemiological and nutri-
tional transitions [34], as well as environmental and social
influences [35], and ethnic differences [36]. As for the
prevalence of MetS compared to other Brazilian studies,the results of this study may reflect the differences in the
statistical analyses [18,19] and fasting glucose cut-off
points [18]. Additionally, regional differences and the
period of data collection (for example the early 2000s) are
factors that deserve consideration.
There is a gradient of risk for CVD with increasing num-
ber of MetS components [37,38]. The identification of per-
sons with zero diagnostic criteria of MetS, a group that
comprised 13.6% of our study population, is clinically
Table 2 Crude and adjusted prevalence ratios of metabolic syndrome according to diagnostic components among
adults aged 18 years or older a, by gender (Federal District, Brazil, 2007)
Prevalence ratio (95%CI)
Male Female
Crude Adjustedb Crude Adjustedb
Elevated blood pressure
No 1 1 1 1
Yes 11.01 (6.41 – 18.93) 5.10 (3.17 – 8.22) 6.29 (4.96 – 7.98) 2.45 (2.02 – 2.97)
Elevated fasting glucose
No 1 1 1 1
Yes 4.62 (3.52 – 6.05) 1.80 (1.47 – 2.20) 3.98 (3.40 – 4.65) 1.53 (1.36 – 1.72)
Elevated waist circunference
No 1 1 1 1
Yes 4.92 (3.81 – 6.36) 1.63 (1.30 – 2.03) 11.26 (8.55 – 14.83) 5.02 (3.77 – 6.69)
Elevated triglycerides
No 1 1 1 1
Yes 6.78 (4.28 – 10.72) 3.03 (2.26 – 4.86) 4.32 (3.64 – 5.13) 1.84 (1.63 – 2.08)
Low HDLc
No 1 1 1 1
Yes 5.82 (3.49 – 9.71) 2.97 (1.95 – 4.51) 4.63 (3.32 – 6.44) 2.71 (2.14 – 3.45)
a Weighted to represent distributions of population aged 18 years or older, according to gender, age and education based on Brazilian national census for the year
2000.
b Adjusted for all other MetS diagnostic components.
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reduced risk of developing CVD [39]. Those without any
risk should be an important target for the identification of
the beneficial factors associated with protection against
MetS.
The difference between genders in which three com-
ponents most strongly accounted for the diagnosis of
MetS in our sample was unexpected (Table 2). The
practical utility of this information is the knowledge
that hypertension in men and abdominal obesity in
women could be the single best predictors of MetS
related co-morbidity for screening purposes.
Although the World Health Organization [40] identi-
fied environmental factors such as smoking, low intake
of fruit and vegetables, physical inactivity, and other fac-
tors as important contributors to a large proportion of
mortality attributed to CVD, no association was
observed between behavioral correlates and MetS in the
present study (Tables 3 and 4). Similar results were
described in a recent cohort study for MetS in Portugal
[41], and these results point to the complex nature of
MetS-associated factors.
The strong association between abdominal obesity
and MetS is well-recognized [42,43]. In the unified
statement on the definition of MetS, the WC is the
only parameter to be evaluated according to popula-
tion and country-specific definitions [3]. The unified
consensus suggests WC ≥ 90 cm for male and ≥ 80 cmfor female as thresholds for abdominal obesity among
ethnic South and Central Americans, derived from
Asian population studies [44]. However, the assign-
ment of these cutoff points does not fit the ethnic
characteristics of the entire population living in these
regions [45], such as the Brazilian population. Brazil
has a highly heterogeneous population, with inter-
ethnic admixtures of people from European, African
and indigenous backgrounds [46]. A recent study on
the genomic ancestry of different geographical regions
of Brazil has ratified the predominance of European
ancestry among Brazilians [24]. Thus, the use of
≥102 cm for men and ≥ 88 cm for women as WC cut
points in our study was a pragmatic decision based
on the above rationale, as recognized in the 2009 har-
monized consensus [3]. Further studies are needed to
define the WC cut points representative of the Brazil-
ian population.
Our study identified education as a protective factor
against MetS in women (PR 0.66, 95% CI: 0.49–0.89),
which is in agreement with other studies [21,36,47]. Ana-
lyzing the age category (results not shown), women with
12 or more years of schooling tended to be in the younger
categories. The increased number of women with 12 or
more years of education is a recent phenomenon in Brazil
[48], and it may partly explain the observed result. Among
South Koreans, women with less education tended to be
in the older birth cohorts and had a higher prevalence of
Table 3 Prevalence (%), crude and adjusted prevalence ratios of metabolic syndrome among male adults aged 18 years
or older a, by selected sociodemographic, behavioral, nutritional and health status variables (Federal District, Brazil,
2007)
Prevalence (95%CI) Prevalence ratio (95%CI)
Crude Adjustedb Adjustedc
Age (years)
18–24 7.3 (0.0 – 14.8) 1 1 1
25–34 24.4 (16.0 – 32.7) 3.35 (1.27 – 8.88) 3.35 (1.27 – 8.88) 2.47 (1.15 – 5.33)
35–44 35.4 (26.3 – 44.4) 4.87 (1.94 – 12.2) 4.87 (1.94 – 12.2) 3.06 (1.44 – 6.51)
45–54 55.3 (44.2 – 66.4) 7.60 (3.08 – 18.7) 7.60 (3.08 – 18.7) 3.70 (1.73 – 7.87)
55–64 65.1 (50.5 – 79.7) 8.95 (3.64 – 22.0) 8.95 (3.64 – 22.0) 4.17 (1.96 – 8.86)
≥ 65 57.4 (41.7 – 73.1) 7.89 (3.14 – 19.8) 7.89 (3.14 – 19.8) 4.25 (1.97 – 9.17)
Residence time in Federal District (years)
< 10 20.8 (9.9 – 31.8) 1 1
10–19 24.8 (15.8 – 33.8) 1.19 (0.63 – 2.25) 1.17 (0.65 – 2.10)
20–29 26.6 (16.6 – 36.6) 1.28 (0.70 – 2.33) 1.17 (0.68 – 2.00)
≥30 45.5 (38.6 – 52.4) 2.19 (1.30 – 3.67) 1.16 (0.70 – 1.94)
Marital status
Single 14.8 (8.7 – 20.9) 1 1
Married/living with partner 41.4 (35.0 – 47.7) 2.79 (1.74 – 4.47) 1.36 (0.78 – 2.35)
Widowed/separated 43.4 (16.4 – 70.4) 2.93 (1.47 – 5.84) 1.21 (0.62 – 2.37)
Current physical activity level
Active 26.3 (20.5 – 32.2) 1 1
Insufficiently active 35.6 (22.2 – 49.0) 1.35 (0.90 – 2.03) 1.24 (0.86 – 1.79)
Inactive 41.8 (29.9 – 53.6) 1.58 (1.13 – 2.22) 1.23 (0.92 – 1.63)
Body mass index (kg/m2)
Normal (<25) 6.4 (3.3 – 9.4) 1 1 1
Overweight(25–29) 38.4 (31.8 – 44.9) 6.03 (3.52 – 10.3) 4.52 (2.64 – 7.74) 4.40 (2.57 – 7.55)
Obese (≥30) 84.9 (73.7 – 96.1) 13.3 (8.05 – 22.1) 9.99 (5.92 – 16.9) 9.77 (5.79 – 16.5)
Total cholesterol (mg/dL)
<200 23.4 (17.2 – 29.6) 1 1 1
≥200 42.9 (34.6 – 51.1) 1.83 (1.32 – 2.54) 1.43 (1.08 – 1.91) 1.14 (0.91 – 1.42)
a Weighted to represent distributions of population aged 18 years or older, according to gender, age and education based on Brazilian national census for the year
2000.
b Adjusted for age.
c Adjusted for age, body mass index and total cholesterol.
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economic status during childhood and adulthood, includ-
ing education, seems to influence the risk of MetS [49].
An assessment of potential mediators of educational in-
equalities in our population in the context of the transition
process in developing countries and how they affect men
and women differently could identify the best exponents
of this phenomenon.
Likely limitations of our study are related to the nature
of cross-sectional studies, including the potential for sur-
vival bias and temporal ambiguity. Considering that diag-
nostic factors and other correlates that constitute MetS
may fluctuate over time, the diagnostic accuracy may in-
crease with subsequent data acquisition. In our sample,
women were clearly over-represented, but we minimizedthis effect by applying adjustment methods. The strengths
of this study lie in the probabilistic sampling and the use
of prevalence ratios in the multivariate analyses, making
these results a sound basis for planning public health
interventions.
Conclusions
In conclusion, our study revealed that 32.0% of the
adult population of Brazil’s FD had MetS in 2007. The
components of this syndrome were gender-specific,
and education was protective for women. The study
enabled a sound measure of MetS for data compari-
son and suggests that reducing education inequalities
may be an important public policy goal to improve
health outcomes, especially among women.
Table 4 Prevalence (%), crude and adjusted prevalence ratios of metabolic syndrome among female adults aged
18 years or older a, by selected sociodemographic, behavioral, nutritional and health status variables (Federal District,
Brazil, 2007)
Prevalence (95%CI) Prevalence ratio (95%CI)
Crude Adjustedb Adjustedc
Age (years)
18–24 10.3 (3.7 – 17.0) 1 1 1
25–34 21.3 (16.0 – 26.5) 2.06 (1.13 – 3.74) 2.06 (1.13 – 3.74) 1.67 (0.98 – 2.83)
35–44 37.4 (31.6 – 43.2) 3.62 (2.04 – 6.44) 3.62 (2.04 – 6.44) 2.18 (1.31 – 3.66)
45–54 56.0 (47.2 – 64.9) 5.42 (3.08 – 9.55) 5.42 (3.08 – 9.55) 2.72 (1.61 – 4.60)
55–64 67.9 (59.7 – 76.1) 6.57 (3.74 – 11.55) 6.57 (3.74 – 11.55) 2.88 (1.69 – 4.90)
≥ 65 77.0 (68.4 – 85.5) 7.45 (4.23 – 13.11) 7.45 (4.23 – 13.11) 3.31 (1.90 – 5.75)
Education (years)
0–8 43.5 (37.2 – 49.7) 1 1 1
9–11 24.7 (20.5 – 29.0) 0.57 (0.46 – 0.70) 0.78 (0.64 – 0.96) 0.87 (0.73 – 1.04)
≥ 12 20.5 (14.4 – 26.6) 0.47 (0.33 – 0.67) 0.51 (0.37 – 0.70) 0.66 (0.49 – 0.89)
Residence time in Federal District (years)
< 10 21.9 (14.7 – 29.1) 1 1
10–19 28.8 (23.1 – 34.5) 1.31 (0.93 – 1.85) 1.14 (0.83 – 1.57)
20–29 28.8 (23.1 – 34.5) 1.31 (0.93 – 1.85) 1.14 (0.83 – 1.57)
≥30 49.7 (43.8 – 55.7) 2.27 (1.70 – 3.03) 1.10 (0.82 – 1.47)
Marital status
Single 20.3 (15.5 – 25.2) 1 1 1
Married/living with partner 34.8 (30.0 – 39.6) 1.71 (1.32 – 2.22) 1.22 (0.95 – 1.57) 0.95 (0.77 – 1.17)
Widowed/separated 58.3 (50.4 – 66.1) 2.87 (2.20 – 3.74) 1.28 (0.99 – 1.66) 1.03 (0.83 – 1.29)
Extra table salt
No 35.0 (30.8 – 39.2) 1 1
Yes 28.0 (20.7 – 35.3) 0.80 (0.64 – 1.00) 0.92 (0.75 – 1.12)
Alcohol consumptiong
Never 36.8 (32.7 – 40.8) 1 1 1
No abusive 23.8 (15.8 – 31.9) 0.65 (0.49 – 0.86) 0.74 (0.55 – 0.99) 0.90 (0.69 – 1.17)
Abusive 21.7 (10.4 – 33.0) 0.59 (0.36 – 0.97) 0.75 (0.50 – 1.13)e 0.71 (0.48 – 1.04)
Smoking
Never 29.4 (25.7 – 33.1) 1 1
Former smokers 55.0 (45.0 – 65.0) 1.87 (1.54 – 2.28) 1.41 (1.18 – 1.67)
Current smokers 34.2 (23.7 – 44.7) 1.16 (0.88 – 1.53) 1.12 (0.86 – 1.46)
Body mass index (kg/m2)
Normal (<25) 8.4 (6.1 – 10.6) 1 1 1
Overweight(25–29) 45.5 (38.3 – 52.8) 5.45 (4.13 – 7.20) 4.29 (3.21 – 5.75) 4.09 (3.07 – 5.46)
Obese (≥30) 78.1 (72.6 – 83.5) 9.34 (7.20 – 12.1) 7.04 (5.32 – 9.31) 6.78 (5.15 – 8.92)
Total cholesterol (mg/dL)
<200 25.5 (20.7 – 30.3) 1 1 1
≥200 46.1 (40.7 – 51.6) 1.81 (1.52 – 2.16) 1.21 (1.02 – 1.43) 1.20 (1.05 – 1.36)
LDLc (mg/dL)
<130 28.1 (23.7 – 32.5) 1 1
130–159 36.3 (30.2 – 42.4) 1.29 (1.05 – 1.58) 0.99 (0.82 – 1.19)
≥160 52.3 (43.9 – 60.7) 1.86 (1.49 – 2.33) 1.09 (0.90 – 1.32)
a Weighted to represent distributions of population aged 18 years or older, according to gender, age and education based on Brazilian national census for the year 2000.
b Adjusted for age.
c Adjusted for age, education, marital status, alcohol consumption, body mass index and total cholesterol.
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